Lpl Financial LLC Emergent Bio Solutions Inc. Transaction History

Lpl Financial LLC

$238 Billion
Q4 2024

A detailed history of Lpl Financial LLC transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 15,120 shares of EBS stock, worth $146,966. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,120

Previous 11,245 34.46%

Holding current value

$146,966

Previous $93,000 54.84%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$7.72 - $11.97 $29,915 - $46,383	3,875 Added 34.46%	15,120 $144,000
Q3 2024 Nov 08, 2024	BUY	$5.72 - $14.77 $64,321 - $166,088	11,245 New	11,245 $93,000
Q4 2023 Feb 14, 2024	BUY	$1.82 - $3.16 $19,406 - $33,695	10,663 New	10,663 $25,000
Q4 2021 Feb 14, 2022	SELL	$33.11 - $55.01 $150,352 - $249,800	-4,541 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$50.07 - $66.05 $16,873 - $22,258	337 Added 8.02%	4,541 $227,000
Q2 2021 Aug 13, 2021	SELL	$56.61 - $80.46 $113,220 - $160,920	-2,000 Reduced 32.24%	4,204 $265,000
Q1 2021 May 14, 2021	SELL	$86.23 - $125.19 $516,345 - $749,637	-5,988 Reduced 49.11%	6,204 $576,000
Q4 2020 Feb 12, 2021	SELL	$79.17 - $111.47 $102,445 - $144,242	-1,294 Reduced 9.6%	12,192 $1.09 Million
Q3 2020 Nov 09, 2020	BUY	$81.91 - $134.94 $575,090 - $947,413	7,021 Added 108.6%	13,486 $1.39 Million
Q2 2020 Aug 13, 2020	BUY	$54.33 - $89.52 $351,243 - $578,746	6,465 New	6,465 $511,000
Q1 2019 May 08, 2019	SELL	$48.23 - $66.16 $317,835 - $435,994	-6,590 Closed	0 $0
Q4 2018 Feb 07, 2019	BUY	$55.63 - $73.24 $366,601 - $482,651	6,590 New	6,590 $391,000

Others Institutions Holding EBS

# of Institutions

168

Shares Held

36.3M

Call Options Held

352K

Put Options Held

770K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $485M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account

Lpl Financial LLC Emergent Bio Solutions Inc. Transaction History